Trial intelligence / Profile preview

Paricalcitol effect on creatinine in CKD

NCT01163162Phase 4Completed

Sponsor
Indiana University
Start
Aug 2010
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of paricalcitol oral solution in chronic kidney disease (CKD), sponsored by Indiana University. Started Aug 2010; status: completed.

02

Drugs

paricalcitol oral solution
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT01163162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01163162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call